Physician

Ryan F Porter, MD

According to 2025 Medicare claims, Ryan Porter, MD (NPI: 1578725651) practices hematology/oncology in the Madison, WI market, with the plurality of this provider's patient population coming from Dane, WI. This provider's primary affiliated billing organization is DEAN HEALTH SYSTEMS, INC (NPI: 1053358846; TIN: 391128616) and primary practice location at 53715-1909. Porter is affiliated with the SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Porter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 483 traditional Medicare patients, billed 106,748 HCPCS/CPT codes, and received $2,866,703 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,192 prescription claims across 316 beneficiaries totaling $3,755,051 in drug costs, led by Erleada (Apalutamide). DME data shows 23 claims. Open Payments data shows 12 records totaling $859,766. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $526,072 to $2,866,703. Similarly, Part D prescription costs have moved sharply higher in recent years, from $280,381 to $3,755,051. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,895 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	264	37,519	$526,072
2016	306	39,605	$516,926
2017	328	43,712	$652,231
2018	338	50,541	$793,343
2019	350	91,240	$1,843,308
2020	367	63,016	$1,182,312
2021	369	71,198	$1,710,694
2022	395	79,017	$1,635,038
2023	432	75,059	$1,631,542
2024	483	106,748	$2,866,703

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	484	$280,381
2016	144	707	$676,314
2017	158	675	$738,474
2018	173	823	$1,398,396
2019	216	1,165	$1,332,773
2020	242	1,422	$1,965,198
2021	251	1,527	$2,671,982
2022	256	1,673	$3,425,666
2023	280	1,697	$3,322,404
2024	316	2,192	$3,755,051

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	37	$817
2016	N/R	63	$15,969
2017	14	48	$580
2018	11	51	$515
2019	N/R	24	$3,230
2020	N/R	12	$2,096
2021	N/R	50	$4,525
2022	N/R	35	$1,100
2023	N/R	15	$3,986
2024	N/R	23	$679

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	239	628	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	162	203	$56
96402	Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle	95	200	$23
36415	Insertion of needle into vein for collection of blood sample	238	736	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	140	528	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	47	1,410	$680,262
Inlyta	Axitinib	36	1,058	$573,510
Xtandi	Enzalutamide	31	930	$418,355
Cabometyx	Cabozantinib S-Malate	16	480	$399,369
Nubeqa	Darolutamide	19	570	$229,385

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$454
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	12	$859,766	BeiGene, Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ryan F. Porter, MD?

Tedicare shows public-source Medicare data for Ryan F. Porter, MD (NPI 1578725651), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan F. Porter, MD have ACO affiliation data?

Ryan F. Porter, MD is shown with ACO affiliation data for SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to Ryan F. Porter, MD?

Ryan F. Porter, MD is linked to DEAN HEALTH SYSTEMS, INC (billing NPI 1053358846) in the available physician profile data.

Does Ryan F. Porter, MD have Open Payments data?

Ryan F. Porter, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.